Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemiasFranck E. Nicolini, Jörge E. Cortes, Grzegorz Basak et al.|Blood|2011Cited by 61
Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patientsFabienne Venet, Arnaud Friggeri, Marie-Angélique Cazalis et al.|Critical Care|2016Cited by 52
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimensMarie Y. Detrait, Mauricette Michallet, Valérie Dubois et al.|Experimental Hematology|2012Cited by 31
Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter CohortFranck E. Nicolini, Delphine Réa, Marie‐Claude Gagnieu et al.|Blood|2013Cited by 27
Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French–Swiss retrospective studyMarie Y. Detrait, Valérie Dubois, Stéphane Morisset et al.|Bone Marrow Transplantation|2015Cited by 21